Edesa Biotech Reports Fiscal 3rd Quarter 2022 Results
Press release content from Accesswire. The AP news staff was not involved in its creation.
Stay updated with breaking news from Clinical Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Press release content from Accesswire. The AP news staff was not involved in its creation.
/PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative...
/PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative...
Cyteir Therapeutics Reports Second Quarter 2022 Financial Results and Operational Highlights - Sharpening focus on the pipeline extends cash runway into second... | August 8, 2022
NXP800 Phase 1a Dose-Escalation Study Progressing as Planned, Commencement of Phase 1b Expansion Study Expected in Q1 2023NXP800 IND Cleared by the U.S. FDA, U.S. and U.K. Sites Now Participating in... | August 5, 2022